Theratechnologies Aktien im Umlauf
Was ist das Aktien im Umlauf von Theratechnologies?
Aktien im Umlauf von Theratechnologies, Inc. ist 95.142M
Was ist die Definition von Aktien im Umlauf?
Im Umlauf befindliche Aktien sind alle Aktien einer Gesellschaft oder eines finanziellen Vermögenswertes, die von Anlegern genehmigt, ausgegeben und gekauft wurden und von diesen gehalten werden.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Aktien im Umlauf von Unternehmen in Health Care Sektor auf TSX im Vergleich zu Theratechnologies
Was macht Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Unternehmen mit aktien im umlauf ähnlich Theratechnologies
- Shriro hat Aktien im Umlauf von 95.088M
- Lilis hat Aktien im Umlauf von 95.098M
- Western Asset High Income Opportunity Fund Inc hat Aktien im Umlauf von 95.099M
- Monadelphous hat Aktien im Umlauf von 95.122M
- Silver Viper Minerals hat Aktien im Umlauf von 95.130M
- Beijing Chunlizhengda Medical Instruments Co hat Aktien im Umlauf von 95.140M
- Theratechnologies hat Aktien im Umlauf von 95.142M
- GasLog Ltd hat Aktien im Umlauf von 95.193M
- Gainey Capital hat Aktien im Umlauf von 95.196M
- Nano One Materials hat Aktien im Umlauf von 95.230M
- Voltalia hat Aktien im Umlauf von 95.244M
- Lithoquest Diamonds hat Aktien im Umlauf von 95.244M
- Prosperity Bancshares hat Aktien im Umlauf von 95.261M